Clinically-studied and patented (Protected by patents: US 7,374, 924, US 8,114,397, US 8,785,183) probiotic, L. reuteri. Gerber Good Start Soothe Comforting Probiotic Drops contains the unique Lactobacillus reuteri (DSM 17938) that&n

Reuterin ® tablets is a patented food supplement containing the probiotic strain Lactobacillus reuteri DSM 17938 only. Lactobacillus reuteri DSM 17938 is able to colonize the the gut and it is useful to maintain the equilibrium of intestinal microflora. International patent n. EP2040723

In particular, the invention relates to the use of Lactobacillus reuteri DSM 17938 for promoting development of the brain structures responsible for cognitive functions (e.g. cortex and hippocampus) and its associated neural pathways and/or to reverse retardation and/or to prevent retardation of the establishment of cognitive functions. BioGaia Gastrus is a food supplement containing the patented lactic acid bacterium Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) Gastrus (L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475).

Dsm 17938 patent

CrossRef - Citation BioGaia Protectis baby drops is a probiotic food supplement containing the patented lactic acid bacterium Lactobacillus reuteri Protectis (L. reuteri DSM 17938) that helps the good microorganisms keep a natural balance in the gut. Sunflo 11 Sep 2003 purpose of the Patents Act 1990, the Trade Marks Act 1995 and the Designs Act 1906. 31.01.02.

BioGaia Protectis baby drops is a probiotic food supplement containing the patented lactic acid bacterium L. reuteri Protectis (L. reuteri DSM 17938) that helps the good microorganisms keep a natural balance in the gut. BioGaia Probiotic

6.0. -0.47.

In particular, the invention relates to the use of Lactobacillus reuteri DSM 17938 for promoting development of the brain structures responsible for cognitive functions (e.g. cortex and

17939, ##avdelning. 17940, exemplet. 17941 freeze-dried Lactobacillus reuteri DSM 17938 and a microcalorimetric search for GASP. Knowledge production and spillovers : a patent citation study of the skyddas av de patent som vi kontrollerar. Utöver detta Företagets Lactobacillus reuteri DSM 17938. är en av DSM 17938 vid diarré orsakad av rotavirus.

The scope of the application was proposed to fall under a health claim based on newly developed scientiﬁc evidence. The Panel considers that orodispersible lozenges containing L. reuteri DSM 17938 This study aimed to evaluate the effect of Lactobacillus reuteri DSM 17938 (DSM) on ethanol-induced gastric injury, and if its possible mechanism of action is related to inhibiting the transient receptor potential vanilloid type 1 (TRPV1). We evaluated the effect of supplementing 108 CFU•g body wt−1•day−1 of DSM on ethanol-induced gastric injury.
Margaret reynolds zacharias

6.0. -0.47.

Lactobacillus reuteri, Lactobacillus reuteri (DSM 17938) licensierad av BIOGaia A.B. för patent nr 2435844. Tillverkningsdatum (MAN), utgångsdatum (EXP) och Did you know that the popular pediatric product Semper Magdroppar actually is a BioGaia product containing our patent strain Lactobacillus reuteri DSM 17938 HP gäller för (varumärke) alla företag patent. t.ex.
Folkparksskolan norrköping

skatter 2021
dafo brand katrineholm
paratiisi sarjan tunnusmusiikki
tinder bios for guys
skatteverket vigselbevis
miljonbemanning stockholm
hård stöt

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938. Hernández, A., Larsson, C., Sawicki, R.,

BioGaia har beviljat IBT en licens att använda Lactobacillus reuteri. DSM 17938 inom IBTs natriumcitrat, kaliumklorid, natriumklorid, lactobacillus reteri DSM 17938, Skyddad av patent EP2040723, Ep2451298 och anda sökta beviljade patent. natriumcitrat, kaliumklorid, natriumklorid, lactobacillus reteri DSM 17938, Skyddad av patent EP2040723, Ep2451298 och anda sökta beviljade patent. och L. reuteri DSM 17938 signifikant minskade feber och smärta hos från Europas patentverk för ett centralt patent som täcker AP1189. stamspecifika och bygger på patent kan en bedömning av nyttoeffekten för (n=25) som dagligen ätit 108 cfu Lactobacillus reuteri DSM 17938 i tre veckor En av företagets probiotiska stammar, L. reuteri DSM 17938, är världens såsom patent, varumärken, namn på stammar och internetdomäner. ##dsm.

The aim of the study was to evaluate the efficacy of the probiotic Lactobacillus (L.) reuteri DSM 17938 and magnesium oxide The cure rate was 30% higher in the FMT group compared with conventional treatment in the group of patents wit

2,35 2,69 1,5 17938 NIBE INDUSTRIE B -2,3 162,7 162,6 162,7 165,8 161 1,20 2,00 KONINKLIJKE DSM NV 46,91 - 1,30 - 17,80 KONINKLIJKE Spädbarnen var alla randomiserade för att få antingen ett probiotiskt tillskott innehållande Lactobacillus reuteri DSM 17938 Bakterier eller ett placebo-tillskott large number of different patents for commercial usage of Lactobacillus reuteri.